P1634: EFFICACY AND SAFETY OF ELTROMBOPAG IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION PATIENTS WITH THROMBOCYTOPENIA（HBV-TP）: A PROSPECTIVE, MULTI-CENTER, SINGLE ARM, PHASE II TRAIL

• Y. Chen,
• Y. Huang,
• Y. Lai,
• J. Peng,
• Z. Zhou,
• H. Zhou,
• R. Zhou,
• R. Yang,
• L. Zhang

Affiliations

Y. Chen

1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin

Y. Huang

2 The First Affiliated Hospital of Xiamen University, Xiamen

Y. Lai

3 The Second Affiliated Hospital of Guangxi Medical University, Nannin

J. Peng

4 Qilu Hospital of Shandong University, JInan

Z. Zhou

5 The Second Affiliated Hospital of Kunming Medical University, Kunmin

H. Zhou

6 Henan Cancer Hospital, Zhengzhou

R. Zhou

7 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjin, China

R. Yang

1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin

L. Zhang

1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin